221 related articles for article (PubMed ID: 24860162)
1. Mechanisms promoting escape from mitotic stress-induced tumor cell death.
Sinnott R; Winters L; Larson B; Mytsa D; Taus P; Cappell KM; Whitehurst AW
Cancer Res; 2014 Jul; 74(14):3857-69. PubMed ID: 24860162
[TBL] [Abstract][Full Text] [Related]
2. DT-13 synergistically enhanced vinorelbine-mediated mitotic arrest through inhibition of FOXM1-BICD2 axis in non-small-cell lung cancer cells.
Li H; Sun L; Li H; Lv X; Semukunzi H; Li R; Yu J; Yuan S; Lin S
Cell Death Dis; 2017 May; 8(5):e2810. PubMed ID: 28542137
[TBL] [Abstract][Full Text] [Related]
3. Antagonizing the spindle assembly checkpoint silencing enhances paclitaxel and Navitoclax-mediated apoptosis with distinct mechanistic.
Henriques AC; Silva PMA; Sarmento B; Bousbaa H
Sci Rep; 2021 Feb; 11(1):4139. PubMed ID: 33603057
[TBL] [Abstract][Full Text] [Related]
4. Synthetic lethal screen identification of chemosensitizer loci in cancer cells.
Whitehurst AW; Bodemann BO; Cardenas J; Ferguson D; Girard L; Peyton M; Minna JD; Michnoff C; Hao W; Roth MG; Xie XJ; White MA
Nature; 2007 Apr; 446(7137):815-9. PubMed ID: 17429401
[TBL] [Abstract][Full Text] [Related]
5. A synthetic podophyllotoxin derivative exerts anti-cancer effects by inducing mitotic arrest and pro-apoptotic ER stress in lung cancer preclinical models.
Chen JY; Tang YA; Li WS; Chiou YC; Shieh JM; Wang YC
PLoS One; 2013; 8(4):e62082. PubMed ID: 23646116
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancer.
Chong T; Sarac A; Yao CQ; Liao L; Lyttle N; Boutros PC; Bartlett JMS; Spears M
J Ovarian Res; 2018 Apr; 11(1):27. PubMed ID: 29618387
[TBL] [Abstract][Full Text] [Related]
7. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells.
Chung KS; Choi HE; Shin JS; Cho YW; Choi JH; Cho WJ; Lee KT
Carcinogenesis; 2013 Aug; 34(8):1852-60. PubMed ID: 23615402
[TBL] [Abstract][Full Text] [Related]
8. Polo-like kinase 1 inhibitor BI2536 causes mitotic catastrophe following activation of the spindle assembly checkpoint in non-small cell lung cancer cells.
Choi M; Kim W; Cheon MG; Lee CW; Kim JE
Cancer Lett; 2015 Feb; 357(2):591-601. PubMed ID: 25524551
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer.
Ferrarotto R; Goonatilake R; Yoo SY; Tong P; Giri U; Peng S; Minna J; Girard L; Wang Y; Wang L; Li L; Diao L; Peng DH; Gibbons DL; Glisson BS; Heymach JV; Wang J; Byers LA; Johnson FM
Clin Cancer Res; 2016 Apr; 22(7):1674-1686. PubMed ID: 26597303
[TBL] [Abstract][Full Text] [Related]
10. Symplekin specifies mitotic fidelity by supporting microtubule dynamics.
Cappell KM; Larson B; Sciaky N; Whitehurst AW
Mol Cell Biol; 2010 Nov; 30(21):5135-44. PubMed ID: 20823274
[TBL] [Abstract][Full Text] [Related]
11. TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer.
Zhong T; Zhang J; Liu X; Li H
Cell Oncol (Dordr); 2023 Oct; 46(5):1493-1507. PubMed ID: 37219768
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of TRIM25 in Lung Cancer Regulates Tumor Cell Progression.
Qin Y; Cui H; Zhang H
Technol Cancer Res Treat; 2016 Oct; 15(5):707-15. PubMed ID: 26113559
[TBL] [Abstract][Full Text] [Related]
13. Suppression of spindly delays mitotic exit and exacerbates cell death response of cancer cells treated with low doses of paclitaxel.
Silva PM; Ribeiro N; Lima RT; Andrade C; Diogo V; Teixeira J; Florindo C; Tavares Á; Vasconcelos MH; Bousbaa H
Cancer Lett; 2017 May; 394():33-42. PubMed ID: 28249757
[TBL] [Abstract][Full Text] [Related]
14. Gene expression and mitotic exit induced by microtubule-stabilizing drugs.
Chen JG; Yang CP; Cammer M; Horwitz SB
Cancer Res; 2003 Nov; 63(22):7891-9. PubMed ID: 14633718
[TBL] [Abstract][Full Text] [Related]
15. CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells.
Dinić J; Ríos-Luci C; Karpaviciene I; Cikotiene I; Fernandes MX; Pešić M; Padrón JM
Invest New Drugs; 2020 Jun; 38(3):584-598. PubMed ID: 31177401
[TBL] [Abstract][Full Text] [Related]
16. Multiple cancer testis antigens function to support tumor cell mitotic fidelity.
Cappell KM; Sinnott R; Taus P; Maxfield K; Scarbrough M; Whitehurst AW
Mol Cell Biol; 2012 Oct; 32(20):4131-40. PubMed ID: 22869527
[TBL] [Abstract][Full Text] [Related]
17. Boosting the apoptotic response of high-grade serous ovarian cancers with CCNE1 amplification to paclitaxel in vitro by targeting APC/C and the pro-survival protein MCL-1.
Raab M; Kobayashi NF; Becker S; Kurunci-Csacsko E; Krämer A; Strebhardt K; Sanhaji M
Int J Cancer; 2020 Feb; 146(4):1086-1098. PubMed ID: 31286496
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7.
Pan X; Chen Y; Shen Y; Tantai J
Cell Death Dis; 2019 Jun; 10(6):429. PubMed ID: 31160576
[TBL] [Abstract][Full Text] [Related]
19. TRIM37 controls cancer-specific vulnerability to PLK4 inhibition.
Meitinger F; Ohta M; Lee KY; Watanabe S; Davis RL; Anzola JV; Kabeche R; Jenkins DA; Shiau AK; Desai A; Oegema K
Nature; 2020 Sep; 585(7825):440-446. PubMed ID: 32908304
[TBL] [Abstract][Full Text] [Related]
20. Post-slippage multinucleation renders cytotoxic variation in anti-mitotic drugs that target the microtubules or mitotic spindle.
Zhu Y; Zhou Y; Shi J
Cell Cycle; 2014; 13(11):1756-64. PubMed ID: 24694730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
